image

The best stocks to buy since 1993

Latest issue now available

Supreme - Shares break into new highs

January 2022

Investing in shares may lose you all or some of your money. Past performance is no indication of future performance. Some of the shares recommended here may be small company shares, which can be relatively illiquid and hard to trade and this makes such shares more risky than other investments.

  • Epic Code:
  • SUP
  • Price:
  • 234p
A string of new share price highs followed an H1 update. No inflationary headwinds were evident and in fact Supreme saw gross profit margin actually rise from 25% to 30%. This is, of course, partly down to the greater proportion of products manufactured in house (61% from 56%) but chief executive Sandy Chadha says it is also down to being able to pull levers with suppliers.Overall H1 sales were +11% to £61.1m, pretax profit +25% to £8.5m and eps +13% to 5.2p. A maiden 2.2p dividend was paid. In terms of owned products, the Vaping category grew revenues organically by 13% to £21.7m, driven by new supply agreements into Sainsbury's and McColl's and the expansion of the contract with HM Prison Service into Scotland. As I had int ...

To access our archive of articles and to receive current issues you need to subscribe.

Subscribe now

Already a subscriber? Login

With small companies there is an above average degree of risk compared to buying blue chips. Please be aware that we have not assessed the suitability of any of these investments for you. The newsletter simply states a personal view and diarises the editor’s investment decisions. Please speak to your stockbroker or other qualified individual to ascertain whether any of these companies mentioned would form useful additions to your own portfolios. Past performance is no indication of future success.

All material on this website is protected by copyright. You may use Information retrieved from the www.scsw.co.uk website for your own personal non-commercial use which means that you may not sell or copy this information to any third party without prior written consent. ISSN 1358-183X

author

LIMITED PERIOD OFFER

SUBSCRIBE TODAY AND SAVE £40 WITH OFFER CODE 40OFFSCSW

To access our archive of articles and to receive current issues you need to subscribe